🇺🇸 FDA
Patent

US 10626147

Cell penetrating peptides and methods of making and using thereof

granted A61KA61K38/00A61K38/05

Quick answer

US patent 10626147 (Cell penetrating peptides and methods of making and using thereof) held by Entrada Therapeutics, Inc. expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Entrada Therapeutics, Inc.
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/00, A61K38/05, A61K38/12, A61K38/465